2014-10-27 09:00 — 2014-10-31 17:00
Cape Town International Convention Centre in Cape Town, South Africa
The HIV Research for Prevention (R4P) conference is the first global conference to cover all forms of biomedical HIV prevention, including AIDS vaccines, microbicides, PrEP, treatment as prevention and other approaches.
The conference concluded on Friday, October 31 but session webcasts and conference reports are available below as are links to slides and the recording of AVAC’s post-R4P webinar—The State of the HIV Prevention Union: The Road from R4P.
AVAC’s Daily Snapshot
Each day, AVAC offered up a selective, whirlwind tour through the day’s sessions—check them out below:
- Day One, Tuesday 28 October
- Day Two, Wednesday, 29 October
- Day Three, Thursday, 30 October
- Day Four, Friday, 31 October
- The State of HIV Prevention Union: The road from R4P webinar, Thursday, 6 November
The conference has made all of the oral presentations, including the opening and closing sessions, available as webcasts. Download them here.
Blog and Social Media
WhatsUpHIV is a live blog set up to report developments from HIV R4P. Over 50 entries were published from advocates, community journalists and researchers.
Ken Mayer has a great summary of the conference in the Lancet.
Download a comprehensive 107-page document of media clippings.
The CBC has dispatches from the conference including news about RV144 and next steps, the growing responsibility of African countries in fighting HIV/AIDS and the advantages of a microbicide gel and vaginal ring for women in preventing HIV
South Africa’s Mail & Guardian published a supplement on the R4P conference.
All conference posters are available here. AVAC posters from R4P are available to download below.
- The Tipping Point: Moving from rhetoric to real milestones for ending AIDS
- Tracking Investments and Expenditures in HIV Prevention Research and Development: Sustaining funding in a shifting international development landscape
- Increasing National Impact and Uptake of Good Participatory Practice Guidelines for Biomedical HIV Prevention (GPP): Three country case studies
- Innovation in Stakeholder Engagement: Piloting a monitoring and evaluation toolkit
- Resource Tracking to Ensure Accountability and Sustainability: HIV prevention, treatment, diagnostics and cure research investment analysis